Clinical Division Genetic Testing and Next Generation Sequencing Services for Active Clinical Protocols- bone marrow failure syndromes, aplastic anemia, myeloid neoplasms, clonal hematopoiesis, and related hematologic disorders
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health NHLBI is seeking genetic testing and next generation sequencing services to support active clinical protocols. This effort focuses on the analysis of bone marrow failure syndromes, aplastic anemia, myeloid neoplasms, clonal hematopoiesis, and other related hematologic disorders. This presolicitation, identified by solicitation number 75N98026Q01002, falls under NAICS code 622110. The performance of these services will take place in Bethesda, Maryland, with a response deadline set for September 8, 2026. Interested parties should contact Noelle K. Decenzo for further information.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
See attached Notice of Intent and Statement of Work for details.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Nhlbi
Same awarding agency
